rs9896398

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_173628.4(DNAH17):​c.4531A>G​(p.Thr1511Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.607 in 1,613,342 control chromosomes in the GnomAD database, including 301,130 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1511I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.62 ( 30346 hom., cov: 34)
Exomes 𝑓: 0.61 ( 270784 hom. )

Consequence

DNAH17
NM_173628.4 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.117

Publications

27 publications found
Variant links:
Genes affected
DNAH17 (HGNC:2946): (dynein axonemal heavy chain 17) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. DNAH17 is a heavy chain associated with axonemal dynein (Milisav and Affara, 1998 [PubMed 9545504]).[supplied by OMIM, Mar 2008]
DNAH17 Gene-Disease associations (from GenCC):
  • spermatogenic failure 39
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.406597E-7).
BP6
Variant 17-78507511-T-C is Benign according to our data. Variant chr17-78507511-T-C is described in ClinVar as Benign. ClinVar VariationId is 402690.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH17NM_173628.4 linkc.4531A>G p.Thr1511Ala missense_variant Exon 28 of 81 ENST00000389840.7 NP_775899.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH17ENST00000389840.7 linkc.4531A>G p.Thr1511Ala missense_variant Exon 28 of 81 5 NM_173628.4 ENSP00000374490.6
DNAH17ENST00000587177.1 linkn.583A>G non_coding_transcript_exon_variant Exon 2 of 7 5

Frequencies

GnomAD3 genomes
AF:
0.624
AC:
94855
AN:
152032
Hom.:
30319
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.734
Gnomad AMI
AF:
0.620
Gnomad AMR
AF:
0.478
Gnomad ASJ
AF:
0.646
Gnomad EAS
AF:
0.466
Gnomad SAS
AF:
0.535
Gnomad FIN
AF:
0.557
Gnomad MID
AF:
0.650
Gnomad NFE
AF:
0.617
Gnomad OTH
AF:
0.631
GnomAD2 exomes
AF:
0.563
AC:
140036
AN:
248814
AF XY:
0.568
show subpopulations
Gnomad AFR exome
AF:
0.732
Gnomad AMR exome
AF:
0.359
Gnomad ASJ exome
AF:
0.650
Gnomad EAS exome
AF:
0.463
Gnomad FIN exome
AF:
0.567
Gnomad NFE exome
AF:
0.615
Gnomad OTH exome
AF:
0.589
GnomAD4 exome
AF:
0.605
AC:
884358
AN:
1461192
Hom.:
270784
Cov.:
89
AF XY:
0.603
AC XY:
438577
AN XY:
726794
show subpopulations
African (AFR)
AF:
0.737
AC:
24685
AN:
33478
American (AMR)
AF:
0.374
AC:
16715
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.648
AC:
16925
AN:
26136
East Asian (EAS)
AF:
0.477
AC:
18911
AN:
39680
South Asian (SAS)
AF:
0.539
AC:
46510
AN:
86248
European-Finnish (FIN)
AF:
0.568
AC:
30324
AN:
53378
Middle Eastern (MID)
AF:
0.649
AC:
3743
AN:
5766
European-Non Finnish (NFE)
AF:
0.620
AC:
689471
AN:
1111454
Other (OTH)
AF:
0.614
AC:
37074
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
22468
44937
67405
89874
112342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18432
36864
55296
73728
92160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.624
AC:
94929
AN:
152150
Hom.:
30346
Cov.:
34
AF XY:
0.617
AC XY:
45870
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.735
AC:
30490
AN:
41504
American (AMR)
AF:
0.478
AC:
7308
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.646
AC:
2242
AN:
3470
East Asian (EAS)
AF:
0.466
AC:
2409
AN:
5172
South Asian (SAS)
AF:
0.533
AC:
2573
AN:
4824
European-Finnish (FIN)
AF:
0.557
AC:
5889
AN:
10580
Middle Eastern (MID)
AF:
0.637
AC:
186
AN:
292
European-Non Finnish (NFE)
AF:
0.617
AC:
41943
AN:
67992
Other (OTH)
AF:
0.626
AC:
1324
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1824
3647
5471
7294
9118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
758
1516
2274
3032
3790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.621
Hom.:
97223
Bravo
AF:
0.623
TwinsUK
AF:
0.619
AC:
2294
ALSPAC
AF:
0.625
AC:
2408
ESP6500AA
AF:
0.736
AC:
3068
ESP6500EA
AF:
0.614
AC:
5214
ExAC
AF:
0.573
AC:
69344
Asia WGS
AF:
0.540
AC:
1881
AN:
3478
EpiCase
AF:
0.619
EpiControl
AF:
0.621

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

DNAH17-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.24
DANN
Benign
0.39
DEOGEN2
Benign
0.0
.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.44
T;T
MetaRNN
Benign
7.4e-7
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
.;.
PhyloP100
0.12
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.0
.;.
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.
Sift4G
Pathogenic
0.0
.;.
Vest4
0.014
ClinPred
0.00030
T
GERP RS
1.6
Varity_R
0.050
gMVP
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9896398; hg19: chr17-76503593; COSMIC: COSV67751281; COSMIC: COSV67751281; API